SCHEMBL13305509

SCHEMBL13305509

NC(=O)CCc1cccc(P)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CAPN1 P07384 1/20 0.44
▸ FFAR1 O14842 3/20 0.42
▸ PRMT1 Q99873 1/20 0.41
▸ PTPRB P23467 1/20 0.40
▸ CDC25A P30304 1/20 0.40
▸ CDC25B P30305 1/20 0.40
▸ PTEN P60484 1/20 0.40
▸ PTPMT1 Q8WUK0 1/20 0.40
▸ KEAP1 Q14145 1/20 0.39
▸ SIRT1 Q96EB6 1/20 0.38
▸ F10 P00742 2/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ NOS3 P29474 1/20 0.38
▸ NOS1 P29475 1/20 0.38
▸ NOS2 P35228 1/20 0.38
▸ SLC22A12 Q96S37 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ AURKA O14965 1/20 0.38
▸ ITGB3 P05106 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28186660 0.79 MAOA (0.57) CAPN1FFAR1PRMT1PTPRBCDC25A
SCHEMBL1617652 0.79 DRD2 (0.60) CAPN1MAPTLMNA
SCHEMBL27705549 0.79 CYP4F2 (0.49) CAPN1FFAR1PRMT1PTPRBCDC25A
SCHEMBL27705548 0.79 CYP4F2 (0.49) CAPN1FFAR1PRMT1PTPRBCDC25A
SCHEMBL4604250 0.79 MAOA (0.57) CAPN1FFAR1PRMT1PTPRBCDC25A
SCHEMBL2857831 0.78 TAAR1 (0.58) FFAR1
SCHEMBL2754670 0.78 TAAR1 (0.58) CAPN1FFAR1
SCHEMBL30344632 0.78 TAAR1 (0.58) FFAR1
SCHEMBL3053513 0.78 TAAR1 (0.58) ALDH1A1LMNA
SCHEMBL22047275 0.78 ALDH1A1 (0.60) CAPN1FFAR1PRMT1PTPRBCDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537116-B1 PYRAZOLOPYRIMIDINES SUITABLE FOR THE TREATMENT OF CANCER DISEASES SCHERING CORP (US) 2010-06-02 — — EP disclosed
Send feedback